Bookmark this page or recommend it.

By taking part in a clinical trial, patients can be treated with new therapeutic techniques, e.g. new drugs, long before they are approved by the regulator. Consequently, you may receive, from a very early stage, the most innovative therapies for your malignant disease. Moreover, the strict international rules, which are binding for CIO clinical trials (What regulations must be complied with in order to ensure the safety of patients in a clinical study?), translate into a high level of security for patients. You are being monitored by recognised clinical experts, side effects are detected early and therefore can be treated effectively.  Research on many cancer patients has shown that patients treated in a clinical trial have a better, i.e. an earlier and more effective control of tumour related symptoms.

In a very large investigation in the U.S.A., women with breast cancer treated in a controlled clinical trial lived longer in comparison to women with breast cancer treated outside a trial. Many patients also see their participation in a clinical trial as an opportunity to be doing something actively to overcome their illness. A further incentive for many patients is knowing that, by participating in such a clinical trial, they are helping develop effective cancer therapies that will be used to treat future cancer patients.

> Back